Table 2.
Variable | Expression Level of SERPINA3 | Cases | Χ2-value | P-value | ||
---|---|---|---|---|---|---|
| ||||||
High | Low | |||||
Tissue Group | Normal | 12 | 48 | 60 | 15.137 | <.0001 |
Cancer | 77 | 80 | 157 | |||
Stage | I | 30 | 64 | 94 | 37.291 | <.0001 |
II | 14 | 13 | 27 | |||
III-IV | 33 | 3 | 36 | |||
Histology Type | G1 | 13 | 33 | 46 | 22.434 | <.0001 |
G2 | 27 | 35 | 62 | |||
G3+UPSC+CC | 37 | 12 | 49 | |||
Menopause | Y | 60 | 57 | 117 | 0.920 | 0.337 |
N | 17 | 23 | 40 | |||
Estrogen Receptor α (ERα) | (+) | 38 | 61 | 99 | 12.187 | <.0001 |
(-) | 39 | 19 | 58 | |||
Progesterone Receptor (PR) | (+) | 57 | 67 | 124 | 2.235 | 0.135 |
(-) | 20 | 13 | 33 | |||
Depth of Myometrial Invasion | ≤50% | 38 | 48 | 86 | 1.796 | 0.180 |
>50% | 39 | 32 | 71 | |||
Lymph node status | (+) | 16 | 0 | 16 | <.0001# | |
(-) | 61 | 80 | 141 | |||
Vascular thrombosis | (+) | 55 | 77 | 126 | 7.429 | 0.006 |
(-) | 22 | 9 | 31 |
Fisher’s exact test; χ2 tests were applied for all other analysis.